Exclusive: The 23 studies the FDA based its expanded leucovorin label on

When the U.S. Food and Drug Administration (FDA) announced during a White House press conference last week that it would expand the use of leucovorin as “a promising treatment for symptoms of autism,” it cited an analysis of 23…